Wheadon David E.
- SEC CIK
- 0001789507
In the past year, 1 open-market purchase filing worth $62.7K and no sales.
Current role at each company
- VXRT Vaxart, Inc.Directoras of Jul 17, 2026
- SHC Sotera Health CoDirectoras of May 27, 2026
- INDV Indivior Pharmaceuticals, Inc.Directoras of May 14, 2026
- SPTX Seaport Therapeutics, Inc.Directoras of May 4, 2026
- CIK 0001771917Directoras of Mar 18, 2024
Show 1 more company
- CIK 0001340652Directoras of Oct 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $62.7K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$62.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wheadon David E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INDV Indivior Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Wheadon David E.Director | PPurchase | +1.77K | $35.39 | +$62.7K | +14.0%14.4K after | 10b5-1 |